Viewing Study NCT00179751


Ignite Creation Date: 2025-12-24 @ 11:50 PM
Ignite Modification Date: 2025-12-25 @ 9:44 PM
Study NCT ID: NCT00179751
Status: TERMINATED
Last Update Posted: 2005-11-07
First Post: 2005-09-10
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase I/II Study of Lenalidomide in Combination With Gemcitabine in Patients With Untreated Advanced Carcinoma of the Pancreas
Sponsor: Celgene Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module